Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma

V Tchekmedyian, EJ Sherman, L Dunn… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE Recurrent or metastatic adenoid cystic carcinoma (R/M ACC) is a malignant
neoplasm of predominantly salivary gland origin for which effective therapies are lacking …
被引用次数：181 相关文章

Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

V Tchekmedyian, EJ Sherman, L Dunn, C Tran… - Journal of Clinical …, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> PURPOSE</jats: title>< jats: p> Recurrent or metastatic adenoid
cystic carcinoma (R/M ACC) is a malignant neoplasm of predominantly salivary gland origin …
[HTML] nih.gov

[HTML][HTML] Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

V Tchekmedyian, EJ Sherman, L Dunn… - Journal of Clinical …, 2019 - ncbi.nlm.nih.gov
PURPOSE Recurrent or metastatic adenoid cystic carcinoma (R/M ACC) is a malignant
neoplasm of predominantly salivary gland origin for which effective therapies are lacking …

Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.

V Tchekmedyian, EJ Sherman, L Dunn… - Journal of Clinical …, 2019 - europepmc.org
PURPOSE: Recurrent or metastatic adenoid cystic carcinoma (R/M ACC) is a malignant
neoplasm of predominantly salivary gland origin for which effective therapies are lacking …

Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

V Tchekmedyian, EJ Sherman… - Journal of clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose Recurrent or metastatic adenoid cystic carcinoma (R/M ACC) is a malignant
neoplasm of predominantly salivary gland origin for which effective therapies are lacking …